Abstract
The most important approach for the management of hereditary fructose intolerance is a strict avoidance of fructose, sucrose and sorbitol from the diet and medications. A safe threshold of 2.4 mg/kg/dose was recently established by the Instituto Superiore di Sanità of Italy for both oral and parenteral routes, thus shouldering a safe administration of a majority of vaccines in these patients. This would not include, Rotarix® pre-established oral suspension and Rotateq® vaccines, which are indeed contraindicated. Moreover, Rotarix® white powder and solvent for oral suspension would only be safely administered at a weight above 9.3 kg. Overall, these recommendations to avoid rotavirus vaccination are difficult to implement because these vaccines are given during exclusive breastfeeding, prior to fructose-containing food introduction.
Author supplied keywords
Cite
CITATION STYLE
Saborido-Fiaño, R., Martinón-Torres, N., Crujeiras-Martinez, V., Couce, M. L., & Leis, R. (2021). Letter to the editor concerning the article ‘Safety of vaccines administration in hereditary fructose intolerance.’ Human Vaccines and Immunotherapeutics. Taylor and Francis Ltd. https://doi.org/10.1080/21645515.2021.1891816
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.